Drug Discovery · Oxford, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. Coding Bio is based in Oxford, United Kingdom and was founded in 2020. It was valued at $6.6 million at its seed round in Sep 2023, the last priced event on record. It has raised $3.6 million across 1 recorded round; the latest was a $3.6 million seed round in Sep 2023.
PMV mark · valuation
$6.6M
Oct 2026
Priced at
its seed round
Sep 2023
Total raised
$3.6M
Last round
Seed Round
Sep 2023
Cap table — not yet on record
Coding Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Coding Bio with a free account
·The complete investor list: 15 names
·Watch Coding Bio: the Monday email on marks, rounds and moves
